Clinical Trial Update: A Study to Understand How the Study Medicine Dazukibart Works in People With Idiopathic Inflammatory Myopathies [Phase 3]

View source ↗

Summary

This is a Phase 3 clinical trial investigating how the study drug Dazukibart works in people with Dermatomyositis and Polymyositis, with recruitment ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dermatomyositis
• Polymyositis

Drugs mentioned

• Dazukibart

Snippet

Sponsor: Pfizer | Conditions: Dermatomyositis, Polymyositis | Phase 3 | Status: RECRUITING